Elite Pharmaceuticals, Inc. Proceeds from Issuance of Other Long-term Debt
Elite Pharmaceuticals, Inc. (ELTP) reported Proceeds from Issuance of Other Long-term Debt of $1.01 million for the 9-month period ending 2020-12-31, per its 10-Q filed 2022-02-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt · last filed 2022-02-14
- Elite Pharmaceuticals, Inc. proceeds from issuance of other long-term debt for the quarter ending 2020-12-31 was $0.00.
| Period end | Proceeds from Issuance of Other Long-term Debt 3 month | Proceeds from Issuance of Other Long-term Debt 6 month | Proceeds from Issuance of Other Long-term Debt 9 month |
|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-14 | $1.01M 10-Q · filed 2022-02-14 | |
| 2020-09-30 | $1.01M 10-Q · filed 2021-11-15 |